Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Journal of Personalized Medicine|November 14, 2020
Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine ApproachEleonora Del Prete, Maria Francesca Beatino, Nicole Campese, et al.Journal of Clinical Medicine|March 6, 2021
Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the DiseaseCiro De Luca, Sara Gori, Sonia Mazzucchi, et al.Headache|July 2, 2015
Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse HeadacheCinzia Lucchesi, Filippo Baldacci, Martina Cafalli, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 12, 2014
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapyMichele Poletti, Daniela Frosini, Cristina Pagni, et al.Headache|January 3, 2013
Triggers in allodynic and non-allodynic migraineurs. A clinic setting studyFilippo Baldacci, Marcella Vedovello, Martina Ulivi, et al.Biomedicines|March 28, 2024
Beyond Pain Relief: Unveiling the Multifaceted Impact of Anti-CGRP/R mAbs on Comorbid Symptoms in Resistant Migraine PatientsAlessandra Della Vecchia, Ciro De Luca, Lucrezia Becattini, et al.Antioxidants (Basel, Switzerland)|November 14, 2019
Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte MembranesRebecca Piccarducci, Simona Daniele, Jonathan Fusi, et al.Parkinsonism & Related Disorders|July 10, 2010
Levodopa response in dementia with lewy bodies: a 1-year follow-up studyClaudio Lucetti, Chiara Logi, Paolo Del Dotto, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 12, 2012
Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's diseaseMichele Poletti, Daniela Frosini, Cristina Pagni, et al.Journal of Alzheimer'S Disease : JAD|August 14, 2022
The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid AngiopathyRebecca Piccarducci, Maria Chiara Caselli, Elisa Zappelli, et al.Pageof 9